CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MHRA (UK)
Original article

MHRA introduces new safeguards to strengthen antidepressant safety information following major review

Regulatoryantidepressant medicinesPositive
AI Analysis

Summary

The MHRA is introducing new and updated patient safety information for antidepressant medicines following a comprehensive review involving patients, families, and independent experts.

Outcome Details

New and updated patient information for antidepressant medicines to be introduced following extensive review

Importance:3/10
Sentiment:
0.30
regulatorysafetyantidepressantspatient informationMHRA

Read the original article

Published by MHRA (UK) on October 15, 2026 8:30 AM

Read Original